Areas of Growth: A Closer Look at Research on Cannabis Propagation
April 7th 2023The field of cannabis horticulture is ever-evolving and offers many opportunities for innovation and experimentation. In this interview, Jessica Lubell-Brand, PhD, professor of horticulture at the University of Connecticut with the Department of Plant Science and Landscape Architecture provides insights into the findings of her laboratory’s recent studies of the “retipping” method of propagating cannabis. She also shares details on her current research with cannabis breeding techniques and how studies like these can benefit the future of cannabis growing.
One Case Study Shows How a Woman in the UK Reduced her Prescription Pain Medication With Cannabis
March 30th 2023A recently published case study documents one chronic pain patient’s reduction of prescribed pain medication after being referred to a medical cannabis registry. Prescribed cannabis-based medicinal products (CBMPs) have been legal in the UK since 2018.
Insights Into the Advantageous Positioning for Europe in Pharmaceutical Cannabis
March 28th 2023Read an interview from Pharmaceutical Technology Europe exploring how the European bio/pharma industry’s high regulatory standards and GMP requirements are set to position the region as a frontrunner for pharmaceutical grade manufacturing of cannabis-based medicines.
More Details on Yale University’s New Research Center for Cannabis and Mental Health
March 2nd 2023In early 2023, Yale School of Medicine announced the foundation of a new center for cannabis research. The center’s inaugural director recently provided commentary on the goals and direction of the research.
Exploring Psychedelics with a Legal Mind
March 1st 2023While many psychedelics are classified as Schedule I drugs under the federal Controlled Substances Act, the recent resurgence of interest in their potential therapeutic benefits means the landscape around psychedelics is rapidly evolving. New laws and regulations are proposed and passed at the local, state, and federal levels. Research continues to increase as well, contributing to the questions and perspectives surrounding the various uses of psychedelics. In this interview, Dustin Robinson, Esq., CPA, Managing Principal of Iter Investments; Co-Founder of Nucleus; Founding Partner of Mr. Cannabis Law; and Co-Founder of Mr. Psychedelic Law explains how he navigates the complex legal landscape of psychedelics, the surprises and challenges he encounters, and how he envisions psychedelics in the United States in the near future.